Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus
about
Is mTOR Inhibitor Good Enough for Treatment All Tumors in TSC Patients?Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapyCutaneous manifestations of tuberous sclerosis complex and the paediatrician's role.Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin.Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway.Tuberous sclerosis complex: Recent advances in manifestations and therapy.Sclerotic bone lesions as a potential imaging biomarker for the diagnosis of tuberous sclerosis complex.Tuberous Sclerosis Complex in 29 Children: Clinical and Genetic Analysis and Facial Angiofibroma Responses to Topical Sirolimus.Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.The LAM Lung Cell and Its Human Cell Models.A diagnostic and management algorithm for individuals with an isolated skin finding suggestive of tuberous sclerosis complex.Clinical Characteristics of Connective Tissue Nevi in Tuberous Sclerosis Complex With Special Emphasis on Shagreen Patches.Fibrous Plaque of the Eyelid in a Patient with Tuberous Sclerosis Responding to Everolimus.Tuberous sclerosis complex: review based on new diagnostic criteria.
P2860
Q28075954-806D1BFC-044B-4543-A8F4-8B2089D73FADQ28078328-0AA719D8-8384-449F-A2BF-1D31A53985ABQ36326114-69C15F64-8FE5-4E23-B936-7897F91D3E24Q36649878-9E3FA794-A96C-499B-8E49-39A5262AF06CQ39021335-104F0A22-2551-4B02-9CE4-DD11C8C846B0Q39408346-FE51766A-F30A-4D23-A0E9-024F50606AB0Q48223051-A72A08EF-41BF-45D5-8D5F-82D24BCD134DQ48297402-4599F467-B0E2-4FB9-B4FA-0589219DC1BBQ48373889-A0E8AB75-89B5-4AC8-A4BC-7A8201A4A89FQ50181460-076FFF77-B366-445F-A647-2C596DA99ED5Q50332677-71E9654C-68C2-4BA6-A7CD-A7D8431808A7Q51033871-E2B112A3-7E9F-40BF-A903-FD7172DDC026Q53076177-EBF8E7E2-F750-4606-9B99-8DD95D87D1A1Q55277251-514647E4-3F04-413E-BBAB-A8086872753D
P2860
Improvement of tuberous sclerosis complex (TSC) skin tumors during long-term treatment with oral sirolimus
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improvement of tuberous sclero ...... treatment with oral sirolimus
@ast
Improvement of tuberous sclero ...... treatment with oral sirolimus
@en
type
label
Improvement of tuberous sclero ...... treatment with oral sirolimus
@ast
Improvement of tuberous sclero ...... treatment with oral sirolimus
@en
prefLabel
Improvement of tuberous sclero ...... treatment with oral sirolimus
@ast
Improvement of tuberous sclero ...... treatment with oral sirolimus
@en
P2093
P2860
P1476
Improvement of tuberous sclero ...... treatment with oral sirolimus
@en
P2093
Edward W Cowen
Ji-an Wang
Mary Haughey
Neera Nathan
Shaowei Li
P2860
P304
P356
10.1016/J.JAAD.2015.07.018
P407
P577
2015-09-10T00:00:00Z